|
Details Of Insider Trading Activities
Transaction | Company | Ticker | Insider | Shares Traded | Avg. Price | Total Value | Filing |
---|
2021-02-05 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 600,000 | $4.50 | $2,700,000 |  | 2021-01-20 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 1,460,280 | $3.42 | $4,994,157 |  | 2020-12-23 Sale | OncoCyte Corp | OCX | KINGSLEY ALFRED D Director | 900 | $2.55 | $2,295 |  | 2020-12-21 Sale | OncoCyte Corp | OCX | KINGSLEY ALFRED D Director | 5,148 | $2.54 | $13,075 |  | 2020-08-03 Purchase | OncoCyte Corp | OCX | ANDREWS RONALD ASBURY Chief Executive Officer, Director | 40,000 | $1.35 | $54,000 |  | 2020-08-03 Purchase | OncoCyte Corp | OCX | KALAJIAN TONY T Sr.VP/Chief Accounting Officer | 5,000 | $1.31 | $6,550 |  | 2020-08-03 Purchase | OncoCyte Corp | OCX | Parker Albert P Chief Operating Officer | 5,000 | $1.33 | $6,650 |  | 2020-04-24 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 1,050,000 | $2.27 | $2,383,500 |  | 2020-03-31 Purchase | OncoCyte Corp | OCX | ANDREWS RONALD ASBURY CEO and President, Director | 18,000 | $2372.00 | $42,696,000 |  | 2020-03-31 Purchase | OncoCyte Corp | OCX | ANDREWS RONALD ASBURY CEO and President, Director | 18,000 | $2.37 | $42,660 |  | 2020-03-30 Purchase | OncoCyte Corp | OCX | ANDREWS RONALD ASBURY CEO and President, Director | 27,216 | $2.26 | $61,508 |  | 2020-03-30 Purchase | OncoCyte Corp | OCX | ANDREWS RONALD ASBURY CEO and President, Director | 27,216 | $2.26 | $61,508 |  | 2020-01-02 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 1,391,466 | $2.16 | $3,005,566 |  | 2020-01-02 Sale | OncoCyte Corp | OCX | Lineage Cell Therapeutics, Inc.
| 2,383,090 | $2.16 | $5,147,474 |  | 2019-11-13 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 1,176,471 | $1.70 | $2,000,000 |  | 2019-09-17 Purchase | OncoCyte Corp | OCX | Arno Andrew Director | 50,000 | $2.16 | $108,000 |  | 2019-09-13 Purchase | OncoCyte Corp | OCX | KALAJIAN TONY T SVP-Chief Accounting Officer | 10,000 | $1.98 | $19,800 |  | 2019-09-12 Purchase | OncoCyte Corp | OCX | Levine Mitchell S Chief Financial Officer | 10,000 | $2.01 | $20,099 |  | 2019-09-12 Purchase | OncoCyte Corp | OCX | Levine Mitchell S CFO | 10,000 | $2.01 | $20,099 |  | 2019-09-11 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 2,000,000 | $1.66 | $3,320,000 |  | 2019-09-11 Sale | OncoCyte Corp | OCX | Lineage Cell Therapeutics, Inc. 10% owner | 4,000,000 | $1.66 | $6,640,000 |  | 2019-07-05 Sale | OncoCyte Corp | OCX | BIOTIME INC 10% owner | 2,250,000 | $2.00 | $4,500,000 |  | 2019-07-02 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 1,000,000 | $2.00 | $2,000,000 |  | 2019-02-08 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 533,333 | $3.75 | $1,999,998 |  | 2018-03-28 Purchase | OncoCyte Corp | OCX | BROADWOOD PARTNERS, L.P. 10% owner | 3,968,254 | $1.26 | $5,000,000 |  |
1
|
|
|